Interstitial Lung Disease
📧 Sign up to get email alerts when something new happens for Interstitial Lung Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Efficacy of L-menthol on Breathlessness in Interstitial Lung Disease [Phase 2]
A Phase 2 clinical trial is evaluating whether inhaled L-menthol reduces breathlessness in people with interstitial lung disease; enrollment…
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF) [Phase 3]
A Phase 3 clinical trial is evaluating the efficacy and safety of inhaled treprostinil for progressive pulmonary fibrosis, with recruitment …
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: A Study to Test Whether Nerandomilast Helps People With Lungfibrosis Related to Rheumatic Diseases [Phase 3]
A Phase 3 study by Boehringer Ingelheim is testing nerandomilast for interstitial lung disease related to systemic autoimmune rheumatic dise…
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD [Phase 2]
Phase 2 clinical trial evaluating mosliciguat in combination with inhaled treprostinil for pulmonary hypertension associated with interstiti…
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: Feasibility of Semaglutide in Advanced Lung Disease [Phase 1, Phase 2]
Feasibility study of the GLP-1 agonist semaglutide for patients with obesity and advanced lung diseases, spanning Phase 1 and Phase 2, curre…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: FIBRONEER-ACT: A Study to Test Whether Nerandomilast Helps People With Fibrosing Interstitial Lung Disease at Risk for Disease Progression [Phase 3]
A Phase 3 trial named FIBRONEER-ACT is evaluating nerandomilast for fibrosing interstitial lung disease at risk for progression. The study i…
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: Early Recognition of Progressive Lung Fibrosis in Systemic Rheumatic Diseases [NA]
A clinical trial update indicating recruitment is ongoing for a study focused on early recognition of progressive lung fibrosis in systemic …
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: An Initial Experience With the Disposable Celsio Cryocatheter System for Diagnostic and Interventional Bronchoscopy [NA]
This update describes initial experience with the disposable Celsio Cryocatheter System for diagnostic and interventional bronchoscopy in lu…
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
This clinical trial registry entry describes the DeciPHer-ILD real-world patient registry focused on Group 3 pulmonary hypertension associat…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis [Phase 3]
A Phase 3 clinical trial evaluating nerandomilast to slow progression in people with familial pulmonary fibrosis and related interstitial lu…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Construction of a Clinico-Imaging Collaborative Diagnostic Model for Dermatomyositis Combined With Interstitial Lung Disease Based on PET/CT Imaging Features and Clinical Parameters
A clinical trial update on building a clinico-imaging diagnostic model for Dermatomyositis with interstitial lung disease using PET/CT featu…
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD) [Phase 3]
This clinical trial update indicates that Insmed's Treprostinil Palmitil Inhalation Powder (TPIP) is being studied in a Phase 3 trial for ef…
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: Optimizing the Diagnostic Journey in Interstitial Lung Disease: The OPTIMIZE-ILD-1 Trial [NA]
The OPTIMIZE-ILD-1 trial aiming to optimize the diagnostic journey for interstitial lung disease is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: Emapalumab MDA5 Rapidly Progressive Interstitial Lung Disease (RP-ILD) Study [Phase 2]
Phase 2 trial update for emapalumab in rapidly progressive interstitial lung disease associated with dermatomyositis; the study is not yet r…
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: Optimizing the Follow-Up Journey in Interstitial Lung Disease: The OPTIMIZE-ILD-2 Trial [NA]
The OPTIMIZE-ILD-2 trial aims to optimize follow-up care for interstitial lung disease and fibrotic ILD, and it is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: Study of the Efficacy of Nintedanib+Tocilizumab in Patients With Systemic Sclerosis and Interstitial Lung Disease [Phase 3]
Phase 3 clinical trial evaluating the combination of nintedanib and tocilizumab for systemic sclerosis with interstitial lung disease is cur…
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants With Progressive Pulmonary Fibrosis [Phase 2]
Phase 2 clinical trial evaluating inhaled AP01 for progressive pulmonary fibrosis is currently recruiting, with no results yet reported.
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: Titrated Ambulatory Oxygen in Fibrotic ILD and COPD With Isolated Exertional Hypoxemia [NA]
A clinical trial evaluating titrated ambulatory oxygen for patients with fibrotic interstitial lung disease and chronic obstructive pulmonar…
-
CLINICAL_TRIALS research · 2026-04-02Clinical Trial Update: Effects of Oxygen Supplementation During the 6-Minute Walk Test in Chronic Respiratory Failure or Exertional Hypoxemia [NA]
A clinical trial update on oxygen supplementation during the 6-minute walk test for people with chronic respiratory failure or exertional hy…
-
CLINICAL_TRIALS research · 2026-04-02Clinical Trial Update: Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension [NA]
A multi-site clinical trial evaluates the clinical impact of an AI-assisted referral approach for diagnosing pulmonary hypertension in patie…
-
CLINICAL_TRIALS research · 2026-04-02Clinical Trial Update: NIVATS Versus IGAVATS: a Pilot Trial Addressing Biopsy Quality in Undetermined Interstitial Lung Diseases [NA]
A pilot study compares NIVATS and IGAVATS for biopsy quality in undetermined interstitial lung diseases and is currently recruiting in Montp…
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: Robotic-Assisted Versus Conventional Bronchoscopy for Cryobiopsy in the Diagnosis of Interstitial Lung Disease [NA]
A ClinicalTrials.gov listing describes a study comparing robotic-assisted versus conventional bronchoscopy for cryobiopsy in diagnosing inte…
-
CLINICAL_TRIALS research · 2026-03-25Clinical Trial Update: Magnetic Resonance Imaging of the Lung: Non-Oncological Applications
This ClinicalTrials.gov entry reports a study evaluating MRI-based lung imaging for non-oncologic applications in Interstitial Lung Disease.…
-
CLINICAL_TRIALS research · 2026-03-20Clinical Trial Update: Impact of Capillaroscopy in the Investigation of Diffuse Interstitial Pneumonias [NA]
This clinical trial update reports ongoing recruitment for a study evaluating capillaroscopy in the investigation of diffuse interstitial pn…
-
CLINICAL_TRIALS research · 2026-03-20Clinical Trial Update: Home-based Pulmonary Rehabilitation and Health Coaching in Patients With Fibrotic Interstitial Lung Disease [NA]
A Mayo Clinic-sponsored clinical trial is evaluating home-based pulmonary rehabilitation and health coaching for patients with fibrotic inte…